InvestorsHub Logo
Followers 35
Posts 6308
Boards Moderated 0
Alias Born 02/09/2015

Re: None

Tuesday, 05/03/2016 8:20:15 AM

Tuesday, May 03, 2016 8:20:15 AM

Post# of 403163
Thinking a bit more about why it is not necessary to load up the the truck and go to Beverly: because no one at CTIX knows the most important information for the success of this company. This of course is whether Kevetrin will benefit cancer patients, or not. Prurisol and Brilacidin will be enough to make CTIX a very successful company if they are beneficial, and especially if B-OM and B-UP work.

The biggest catalyst is Kevetrin, and the trials are the key. In Beverly, you could meet with Dr Menon, and he would tell you the same exact thing. Years ago the early science and early experiments and the potential of Kevetrin would have made for a compelling afternoon.

Now it matters not at all, and all that counts is a real difference in survival in those trials that just have not gotten off the ground yet...

Once again we are left to ponder why? Mayo and CTIX are working on Kevetrin for a phase 2 pancreatic CA trial, but it is not being funded directly, they are trying to get a grant. Just looking at this fact suggests 1) the data are not that good , or 2) CTIX has no money, maybe 3)no one has the time to work on it.

When will we know if K works? Maybe 2 years from now? Maybe 3?


Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent IPIX News